Victor E. Nava

5.0k total citations · 3 hit papers
64 papers, 4.1k citations indexed

About

Victor E. Nava is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Victor E. Nava has authored 64 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 18 papers in Molecular Biology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Victor E. Nava's work include Sphingolipid Metabolism and Signaling (12 papers), Prostate Cancer Treatment and Research (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Victor E. Nava is often cited by papers focused on Sphingolipid Metabolism and Signaling (12 papers), Prostate Cancer Treatment and Research (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Victor E. Nava collaborates with scholars based in United States, Portugal and Poland. Victor E. Nava's co-authors include Sarah Spiegel, Lisa C. Edsall, Sheldon Milstien, Takafumi Kohama, Samantha Poulton, Olivier Cuvillier, J. Marie Hardwick, Rollie J. Clem, Hans Rosenfeldt and John P. Hobson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Victor E. Nava

54 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Edg-1, the G protein–coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation

2000 965 citations Victor E. Nava et al. profile →
Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform

2000 558 citations Masako Sugiura, Victor E. Nava et al. Journal of Biological Chemistry profile →
A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors.

1996 533 citations Victor E. Nava et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victor E. Nava United States	18	3.6k	1.4k	538	391	383	64	4.1k
Ritva Tikkanen Germany	32	2.1k 0.6×	1.6k 1.1×	416 0.8×	271 0.7×	662 1.7×	81	3.3k
Jean Paul ten Klooster Netherlands	23	2.7k 0.8×	1.7k 1.2×	452 0.8×	472 1.2×	305 0.8×	32	4.0k
Nick Morrice United Kingdom	19	3.6k 1.0×	1.0k 0.7×	548 1.0×	672 1.7×	287 0.7×	21	4.6k
Frank T. Cooke United Kingdom	23	3.1k 0.9×	2.1k 1.4×	484 0.9×	304 0.8×	374 1.0×	34	4.3k
Bill X. Wu United States	34	2.3k 0.6×	613 0.4×	597 1.1×	508 1.3×	286 0.7×	52	3.1k
Corinne M. Linardic United States	26	2.7k 0.8×	661 0.5×	346 0.6×	501 1.3×	432 1.1×	55	3.6k
Emmanuel Petroulakis Canada	24	3.6k 1.0×	746 0.5×	822 1.5×	554 1.4×	433 1.1×	27	4.8k
Stefano Fumagalli France	19	3.3k 0.9×	519 0.4×	331 0.6×	560 1.4×	556 1.5×	27	4.1k
Deborah H. Anderson Canada	24	2.8k 0.8×	780 0.5×	641 1.2×	732 1.9×	171 0.4×	59	3.9k
Giuseppe Di Tullio Italy	30	2.4k 0.7×	2.0k 1.4×	338 0.6×	408 1.0×	484 1.3×	42	3.8k

Countries citing papers authored by Victor E. Nava

Since Specialization

Citations

This map shows the geographic impact of Victor E. Nava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor E. Nava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor E. Nava more than expected).

Fields of papers citing papers by Victor E. Nava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor E. Nava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor E. Nava. The network helps show where Victor E. Nava may publish in the future.

Co-authorship network of co-authors of Victor E. Nava

This figure shows the co-authorship network connecting the top 25 collaborators of Victor E. Nava. A scholar is included among the top collaborators of Victor E. Nava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor E. Nava. Victor E. Nava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Diao, Guoqing, et al.. (2025). Investigating Intensity and Percentage of p53 Nuclear Expression in Prostate Cancer: Findings from a Cohort of U.S. Military Veterans. Cancers. 17(6). 1004–1004. 1 indexed citations

Hung, Stevephen, et al.. (2025). Retooling the Massive Transfusion Protocol at a Veterans Affairs Medical Center. Military Medicine. 190(7-8). e1518–e1523.

Nava, Victor E., et al.. (2025). Breast cancer extracellular matrix invasion depends on local mechanical loading of the collagen network. Journal of Materials Chemistry B. 13(27). 8068–8082. 1 indexed citations

Nava, Victor E., et al.. (2024). Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape. Current Oncology. 31(4). 1971–1993. 4 indexed citations

Diao, Guoqing, et al.. (2024). Prevalence of HER3 expression in prostate adenocarcinoma and its clinicopathological characteristics.. Journal of Clinical Oncology. 42(16_suppl). 5019–5019.

Smith, Shane, et al.. (2023). Central Centrifugal Cicatricial Alopecia Associated With PDL1 Loss and Increased Expression of Caspase 3: A Case Series. American Journal of Dermatopathology. 45(6). 418–422. 1 indexed citations

Müller, Daniel J., et al.. (2023). The association of HLA-DR and PD-L1 expression with clinical characteristics in prostate adenocarcinoma.. Journal of Clinical Oncology. 41(16_suppl). e17017–e17017. 1 indexed citations

Nava, Victor E., et al.. (2023). Allelic Variant of Armadillo Repeat Containing Protein 5 (ARMC5) in Myelolipoma Mimicking Pheochromocytoma: A Case Report. Cureus. 15(1). e34454–e34454.

Diao, Guoqing, et al.. (2023). The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma. Annals of Diagnostic Pathology. 67. 152219–152219. 8 indexed citations

10.

Nava, Victor E., et al.. (2022). Neurothekeoma With PI3K w552*, ALK P1469S, SMO G461S, and ERBB3 L77M Genetic Alterations. American Journal of Dermatopathology. 44(12). 958–960. 2 indexed citations

11.

DeRosa, Peter & Victor E. Nava. (2020). Comment on Aasebø, E., et al. “The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles”. Cancers 2020, 12, 1466. Cancers. 12(9). 2461–2461. 1 indexed citations

12.

Zeng, Weifen, Victor E. Nava, Philip L. Cohen, & Metin Özdemirli. (2012). Indolent CD8‐positive T‐cell lymphoid proliferation of the ear: a report of two cases. Journal of Cutaneous Pathology. 39(7). 696–700. 16 indexed citations

13.

Nava, Victor E., et al.. (2010). Hepatocellular carcinoma metastases to facial subcutaneous tissue.. Archives of Pathology & Laboratory Medicine. 134(6). 809–809. 1 indexed citations

14.

Hristov, Alexandra C., Andrew J. Saladino, Victor E. Nava, & Christopher D. Gocke. (2010). Auer rod–like inclusions in a low-grade B-cell leukemia. Annals of Diagnostic Pathology. 14(4). 292–295. 4 indexed citations

15.

Gelfand, Michael, et al.. (2005). Hypoxemic Respiratory Failure in a 57-Year-Old Woman With Acute Monocytic Leukemia. CHEST Journal. 128(5). 3629–3633. 3 indexed citations

16.

Liu, Hong, Rachelle E. Toman, Sravan K. Goparaju, et al.. (2003). Sphingosine Kinase Type 2 Is a Putative BH3-only Protein That Induces Apoptosis. Journal of Biological Chemistry. 278(41). 40330–40336. 309 indexed citations

17.

Cuvillier, Olivier, Victor E. Nava, Lisa C. Edsall, et al.. (2001). Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death and Differentiation. 8(2). 162–171. 119 indexed citations

18.

Nava, Victor E., Olivier Cuvillier, Lisa C. Edsall, et al.. (2000). Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells.. PubMed. 60(16). 4468–74. 138 indexed citations

19.

Nava, Victor E., Emanuela Lacaná, Samantha Poulton, et al.. (2000). Functional characterization of human sphingosine kinase‐1. FEBS Letters. 473(1). 81–84. 91 indexed citations

20.

Brocklyn, James R. Van, et al.. (1999). Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors.. PubMed. 59(24). 6185–91. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact